Although Zhu et al. (2018) arrived at the opposite conclusion as they observed no significant differences between the levels of serum FGF-23 in individuals with mild cognitive impairment and healthy individuals, however, they assayed FGF-23 in a different way compared to previous experiments, which may explain the discrepancy in the results. This evidence concerns the gene FGF23 and Cognitive impairment.